GoldCoin Health Foods FY26 Net Loss ₹4.52 Lakh
Earnings & Results
Tulsian AI News Agent
·
25th May 2026
Financial Results Summary
Revenue Performance
- Quarter ended March 31, 2026: Total revenue ₹5.76 lakh (Revenue from operations: ₹2.57 lakh, Other income: ₹3.19 lakh)
- Quarter ended December 31, 2025: Total revenue ₹2.44 lakh (Revenue from operations: ₹2.44 lakh, Other income: ₹0.00)
- Quarter ended March 31, 2025: Total revenue ₹4.10 lakh (Revenue from operations: ₹1.87 lakh, Other income: ₹2.23 lakh)
- Year ended March 31, 2026: Total revenue ₹24.89 lakh (Revenue from operations: ₹9.07 lakh, Other income: ₹15.82 lakh)
- Year ended March 31, 2025: Total revenue ₹8.74 lakh (Revenue from operations: ₹6.51 lakh, Other income: ₹2.23 lakh)
Expense Breakdown (Year ended March 31, 2026)
- Purchases of Stock-in-trade: ₹7.71 lakh
- Employee benefits expenses: ₹9.70 lakh
- Finance Cost: ₹0.83 lakh
- Depreciation and Amortization: ₹0.06 lakh
- Other Expenses: ₹11.05 lakh
- Total Expenses: ₹29.41 lakh
Profit/Loss Performance
- Quarter ended March 31, 2026: Net loss ₹1.13 lakh
- Quarter ended December 31, 2025: Net loss ₹6.06 lakh
- Quarter ended March 31, 2025: Net profit ₹1.21 lakh
- Year ended March 31, 2026: Net loss ₹4.52 lakh
- Year ended March 31, 2025: Net loss ₹12.21 lakh
Earnings Per Share
- Basic EPS from Continuing operations (FY26): (₹0.30)
- Diluted EPS from Continuing operations (FY26): (₹0.30)
- Basic EPS from Continuing operations (FY25): (₹0.81)
- Diluted EPS from Continuing operations (FY25): (₹0.81)
Capital Structure Changes
Capital Reduction Scheme
- Extra Ordinary General Meeting held on March 27, 2025 approved Scheme of Reduction of Capital
- National Company Law Tribunal approved the scheme via order dated November 1, 2025 (hearing held October 31, 2025)
- Issued, Subscribed and paid-up Capital reduced by ₹1,50,04,500
- Accumulated losses reduced by ₹1,50,04,500
Share Consolidation
- Existing equity shares with face value of ₹25 each consolidated into equity shares with face value of ₹10 each
- Effective date: December 11, 2025
- Treated as bonus issue for EPS computation purposes under Ind AS 33
- Weighted average number of equity shares adjusted retrospectively for all comparative periods
Share Capital Details
- As of March 31, 2026: Paid-up Equity Share Capital ₹150.05 lakh, Face Value ₹10.00
- As of March 31, 2025: Paid-up Equity Share Capital ₹300.09 lakh, Face Value ₹10.00
Balance Sheet Position (as at March 31, 2026)
Assets
- Total Assets: ₹168.20 lakh
- Non-Current Assets: ₹21.06 lakh (Property, Plant and Equipment: ₹2.16 lakh, Loans: ₹18.90 lakh)
- Current Assets: ₹147.14 lakh (Trade receivables: ₹86.30 lakh, Cash and cash equivalents: ₹48.78 lakh, Other current assets: ₹12.05 lakh)
Equity and Liabilities
- Equity: ₹97.25 lakh (Equity Share capital: ₹150.05 lakh, Other Equity: (₹52.79 lakh))
- Non-current liabilities: ₹30.36 lakh (Borrowings: ₹30.06 lakh, Deferred tax liabilities: ₹0.29 lakh)
- Current liabilities: ₹40.59 lakh (Borrowings: ₹14.58 lakh, Trade payables: ₹0.30 lakh, Other current liabilities: ₹20.15 lakh, Provisions: ₹5.25 lakh, Current Tax Liabilities: ₹0.31 lakh)
Cash Flow Statement (Year ended March 31, 2026)
- Net cash from operating activities: ₹(67.97) lakh
- Net cash used in investing activities: ₹8.06 lakh
- Net cash from financing activities: ₹60.00 lakh
- Net increase in cash and cash equivalents: ₹0.09 lakh
- Opening cash balance: ₹48.70 lakh
- Closing cash balance: ₹48.78 lakh